Drug intelligence / Profile preview

Dipyrocetyl

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Oral, Topical
01

Overview

Dipyrocetyl is a small molecule pharmaceutical drug classified as an acylsalicylic acid derivative and member of the salicylates. It is used as an analgesic and antipyretic agent. Dipyrocetyl has also demonstrated potential anticoagulant properties and may inhibit matrix metalloproteinase-2 (MMP2). There is evidence suggesting it could be useful in treating acute lung injury (ALI) associated with acute respiratory distress syndrome (ARDS), possibly by improving tissue integrity and reducing pro-inflammatory cytokine activation. Its primary mechanism of action appears to involve inhibition of prostaglandin synthesis via cyclooxygenase (COX) enzyme inhibition[1][2][4][7].

Brand names
MovireneArtromialgina
Other names
2,3-Bis(acetyloxy)benzoic acido-Pyrocatechuic acid diacetateDiacetylpyrocatechol-3-carboxylic acidDiacetylpyrocatechol3-carboxylic acidDiacetylpyrocatechol 3-carboxylic acid2,3-diacetoxybenzoic acidPyrocat
02

Targets

COXMMP2 (Matrix metalloproteinase-2)

Beyond the preview

Go deeper on Dipyrocetyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dipyrocetyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call